Nature’s Sunshine Products, Inc. (NASDAQ:NATR) Major Shareholder Fosun Pharmaceutical Shanghai Sells 2,854,607 Shares

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) major shareholder Fosun Pharmaceutical Shanghai sold 2,854,607 shares of the stock in a transaction dated Friday, June 27th. The shares were sold at an average price of $11.46, for a total value of $32,713,796.22. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Large shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Nature’s Sunshine Products Stock Performance

NATR opened at $14.50 on Friday. The firm’s fifty day moving average is $13.92 and its two-hundred day moving average is $13.91. The firm has a market cap of $267.67 million, a PE ratio of 27.36 and a beta of 1.16. Nature’s Sunshine Products, Inc. has a twelve month low of $10.81 and a twelve month high of $18.06.

Nature’s Sunshine Products (NASDAQ:NATR) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.25 EPS for the quarter, topping the consensus estimate of $0.16 by $0.09. The business had revenue of $113.25 million for the quarter, compared to the consensus estimate of $109.39 million. Nature’s Sunshine Products had a return on equity of 6.98% and a net margin of 2.22%.

Institutional Investors Weigh In On Nature’s Sunshine Products

Hedge funds have recently modified their holdings of the business. GAMMA Investing LLC raised its holdings in Nature’s Sunshine Products by 2,090.2% during the 1st quarter. GAMMA Investing LLC now owns 2,234 shares of the company’s stock worth $28,000 after buying an additional 2,132 shares during the period. Russell Investments Group Ltd. acquired a new stake in Nature’s Sunshine Products during the 4th quarter worth approximately $41,000. Amundi acquired a new stake in shares of Nature’s Sunshine Products during the fourth quarter worth $63,000. Deutsche Bank AG acquired a new stake in shares of Nature’s Sunshine Products during the fourth quarter worth $103,000. Finally, Wells Fargo & Company MN raised its holdings in shares of Nature’s Sunshine Products by 28.8% during the fourth quarter. Wells Fargo & Company MN now owns 7,209 shares of the company’s stock worth $106,000 after acquiring an additional 1,611 shares during the period. Institutional investors and hedge funds own 79.40% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, DA Davidson reissued a “buy” rating and issued a $19.00 target price on shares of Nature’s Sunshine Products in a research note on Tuesday, June 3rd.

About Nature’s Sunshine Products

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.